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It is now well-established that hematopoietic stem
cells (HSCs) and progenitor cells originate from
a specialized subset of endothelium, termed he-
mogenic endothelium (HE), via an endothelial-to-
hematopoietic transition. However, the molecular
mechanisms determining which endothelial progeni-
tors possess this hemogenic potential are currently
unknown. Here, we investigated the changes in he-
mogenic potential in endothelial progenitors at the
early stages of embryonic development. Using an
ETV2::GFP reporter mouse to isolate emerging endo-
thelial progenitors, we observed a dramatic decrease
in hemogenic potential between embryonic day (E)
7.5 and E8.5. At the molecular level, Runx1 is ex-
pressed at much lower levels in E8.5 intra-embryonic
progenitors, while Bmi1 expression is increased.
Remarkably, the ectopic expression of Runx1 in
these progenitors fully restores their hemogenic po-
tential, as does the suppression of BMI1 function.
Altogether, our data demonstrate that hemogenic
competency in recently specified endothelial pro-
genitors is restrained through the active silencing of
Runx1 expression.INTRODUCTION
Hematopoiesis emerges early in the vertebrate embryo and oc-
curs in threemajor distinctwaves (Costa et al., 2012). The twofirst
waves take place in the extra-embryonic yolk sac (YS) between
embryonic day (E)7.0 and E9.0 and give rise to primitive erythro-
cytes, macrophages, and megakaryocytes (Palis et al., 1999).
The E7.5 primitive wave is rapidly followed by a definitive wave
that begins at E8.25 with the generation of erythro-myeloid pro-
genitors in the YS (Frame et al., 2015; McGrath et al., 2015; Palis
et al., 1999). The first site of intra-embryonic hematopoiesis is theCe
This is an open access article undE9.5 para-aortic splanchnopleura (P-Sp), which further develops
into the aorta-gonad-mesonephros (AGM) region. The AGM is
the site where the first hematopoietic stem cells (HSCs)
with long-term reconstituting and multi-lineage capacity emerge
by E10.5 (Medvinsky et al., 1993; M€uller et al., 1994). Fully
functional HSCs are also detected a day later in the fetal liver
(FL), placenta, and YS (Gekas et al., 2005; Medvinsky and Dzier-
zak, 1996).
It has long been proposed that blood and endothelial lineages
originate from a common mesoderm progenitor. Early studies
pointed to the close proximity of blood and endothelial cells in
the blood island of the YS (Sabin, 1920). More recently, studies
have demonstrated the existence of a common progenitor
termed ‘‘hemangioblast’’ emerging from the primitive streak
and expressing the T-box transcription factor Brachyury (T)
and the fetal liver kinase receptor (Flk1) (Huber et al., 2004).
Cell-fate tracing studies have established the endothelial origin
of hematopoietic cells from a transient cell population termed
‘‘hemogenic endothelium’’ (HE) (Boisset et al., 2010; Jaffredo
et al., 1998; Zovein et al., 2008). Additionally, using an in vitro
system recapitulating YS hematopoiesis, it was shown that the
hemangioblast also gave rise to hematopoietic progenitors via
an HE intermediate (Lancrin et al., 2009). This HE cell population
is characterized by the expression of FLK1, the endothelial tyro-
sine kinase receptor TIE2 (TEK), c-KIT, and VE-cadherin. Initially
HE cells are flat, forming adherent tight endothelial cores, but as
they undergo endothelial-to-hematopoietic transition (EHT), they
acquire a round shape characteristic of circulating blood cells
(Lancrin et al., 2009). We recently showed that Etv2, a member
of the ETS (E26 transformation-specific) family of transcription
factors, marks a subset of mesoderm FLK1+ cells as well as
the next stage of blood specification, the HE. Additionally using
a knockout approach, our study revealed the essential role of
Etv2 for the generation of HE (Wareing et al., 2012a). We and
others also demonstrated the importance of this ETS factor dur-
ing mesoderm specification, using a conditional deletion
approach (Kataoka et al., 2011; Wareing et al., 2012b). ETV2
expression is required in FLK1+ cells for the initiation of the he-
matopoietic program via the activation of the key downstream
target Scl, which, in turn, is critical for the development of HEll Reports 15, 2185–2199, June 7, 2016 ª 2016 The Authors. 2185
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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(Lancrin et al., 2009; Wareing et al., 2012b). Furthermore, ETV2
deficiency in themouse embryos resulted in a complete absence
of all blood progenitors and vascular network (Lee et al., 2008;
Sumanas et al., 2008; Wareing et al., 2012b). The transcription
factor Runx1 was also shown to be critical during hematopoi-
etic specification. Although the HE emerges independently of
Runx1, this factor is crucial for the subsequent formation of
hematopoietic progenitors (Chen et al., 2009; Lancrin et al.,
2009). Moreover, single-cell data generated from Runx1 +23
enhancer-GFP reporter mice revealed activation of the hemato-
poietic program early in GFP+ cells, with a concomitant loss of
the endothelial program (Swiers et al., 2013).
The characterization ofmesoderm-derived cells at the onset of
hematopoiesis allows the identification of the molecular mecha-
nisms that control cell-fate choice toward hemogenic compe-
tence in endothelial cells. We and others have demonstrated
that ETV2 expression marks FLK1+ cells, giving rise to all endo-
thelial and hematopoietic derivatives (Kataoka et al., 2011;Ware-
ing et al., 2012a). To date, it is still not understood how some
endothelial progenitors are endowed with hemogenic compe-
tencywhile others are not. It remains tobedemonstratedwhether
specification toward endothelial or hematopoietic fate is already
pre-determined in specific subsets of ETV2+FLK1+mesoderm or
whether one program is dominant over the other, hence repre-
senting a default fate that needs to be suppressed. While the
hemogenic potential of ETV2+FLK1+ cells has been shown at
E7.5, it is not known whether ETV2+FLK1+ cells at later stages
of development harbor the same characteristics. In this study,
we sought to compare the hemogenic potential of ETV2+FLK1+
cells isolated from E7.5 and E8.5 embryos, using an ETV2::GFP
reporter mouse (Wareing et al., 2012a). We observed that E8.5
ETV2::GFP+FLK1+CD41 cells hadminimal hemogenic potential
compared to their E7.5 counterpart. Microarray and single-cell
gene expression analysis suggested that this differential hemo-
genic potential might be due to a lack of Runx1 expression.
Remarkably, the ectopic expression of Runx1 was able to redi-
rect E8.5 ETV2::GFP+FLK1+ endothelial progenitors toward a
hematopoietic fate. These data not only highlight the plasticity
of ETV2+FLK1+ progenitors in developing embryos but also sug-
gest that hematopoiesis is a fate that is actively suppressed by
the silencing of Runx1 to allow endothelial specification.
RESULTS
ETV2 Expression Marks Similar Immuno-phenotypic
Populations with Distinct Hematopoietic Potential
We previously generated an ETV2::GFP transgenic mouse line
in which GFP marks Etv2-expressing cells; using this mouseFigure 1. ETV2::GFP-Expressing FLK1 Cells Have Different Hematopoi
(A) FACS analysis for the expression of endothelial and hematopoietic markers a
(B) Schematic representation of the experimental design.
(C) FACS analysis of the sorted GFP+FLK1+CD41 cells after three days in HE c
(D) Clonogenic assay for hematopoietic progenitors of FLK1GFPCD41, FLK
three days in culture. Error bars represent 1 SEM from three independent experi
(E) Representative images of hematopoietic colonies from semisolid clonoge
macrophages, Mix, granulocyte-erythroid-monocyte-macrophage (GEMM)/gran
See also Figure S1.model, we showed that, at E7.5, GFP expression marked the
YS wave of HE (Wareing et al., 2012a). A large fraction of
ETV2::GFP+ cells in E7.5 embryos co-expressed c-KIT, TIE2,
and FLK1, all marking the HE subset. Interestingly, ETV2::GFP+
cells from the embryo proper (EP) at E8.5 also co-expressed
these markers, suggesting that this previously uncharacterized
ETV2+ population could share similar hemogenic potential as
the earlier E7.5 ETV2::GFP+ population (Figure 1A). ETV2::GFP+
cells within the YS of E8.5 embryos also co-expressed c-KIT,
TIE2, and FLK1 but had much lower levels of GFP+ expression,
suggesting a progressive downregulation of Etv2 (Figure 1A).
To compare the hemogenic potential of E7.5 and E8.5 (EP)
ETV2::GFP+ cell populations, E7.5 and E8.5 embryos were har-
vested and cells were sorted based on their FLK1+GFP+CD41
immuno-phenotype, followed by plating on OP9 stroma under
conditions that support HE growth and maturation (Figure 1B;
Figure S1A). After 3 days in culture, E7.5 cells upregulated
CD41, indicative of hematopoietic emergence; the majority of
the cultured cells also lost TIE2 expression and either maintained
low levels or lost FLK1 expression. In contrast, while E8.5 cells
also upregulated CD41 expression, they maintained high
expression of the endothelial markers TIE2 and FLK1 (Figure 1C;
Figure S1B). Only a small fraction of CD41+ cells lost expression
of both endothelial markers at the E8.5 stage. This revealed that
the majority of CD41+ cells derived from E8.5 ETV2::GFP+FLK1+
cells maintained an endothelial identity that might prevent further
differentiation toward hematopoiesis. To explore the hematopoi-
etic potential of these populations, cells were further replated in
semisolid clonogenic assays. In line with the flow cytometry
data, the E7.5 ETV2::GFP+FLK1+CD41 population was able to
generate hematopoietic progenitors at much higher levels
when compared to its E8.5 (EP) and E8.5 (YS) counterparts (Fig-
ures 1D and 1E). These data show that the E8.5 HE does not
reside within the E8.5 (YS) ETV2::GFP+ population but raise the
possibility that the YS E8.5 HE could be derived from the E7.5
ETV2::GFP+ progenitors that displayed hemogenic potential.
Finally, although E7.5 and E8.5 (EP) ETV2::GFP+FLK1+CD41
populations both express FLK1, TIE2, and cKIT, markers also
expressed in HE, they differ significantly in terms of their hemo-
genic potential.
The origin of the E8.5 ETV2::GFP+FLK1+ population still re-
mains unclear. Previous work has shown that RUNX1+GATA1
cells from E7.5 extra-embryonic tissue are able to migrate to
the EP in a circulation-independent manner (Tanaka et al.,
2014). This suggests that E7.5 extra-embryonic ETV2+ cells
might similarly migrate to the embryo, giving rise to an intra-
embryonic population. To address this issue, we performed
time-lapse imaging of E7.5 Etv2::gfp embryos. In Figure 2Aetic Potentials at Different Developmental Stages
t the E7.5 and E8.5 developmental stages. EP: embryo proper; YS: yolk sac.
ulture conditions.
1+GFP+CD41, FLK1+GFPCD41, and FLK1+GFP+CD41+ populations after
ments. CFU, colony-forming units; GM, granulocyte-macrophage.
nic assays. EryP, primitive erythrocytes; EryD, definitive erythrocytes; Mac,
ulocyte-erythroid-macrophage (GEM).
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Figure 2. Live Imaging and Microarray Analysis Reveal Migratory Pattern and Differential Gene Expression of ETV2::GFP+ Cells at Different
Developmental Stages
(A) Still images fromMovie S1 displaying themigratory path of some representative ETV2::GFP+ cells during the ex vivo culture of E7.5 embryos. Top: transmitted
and GFP images of Z sections were stacked together to create a 3D reconstruction of the embryo. Bottom: tracking of ETV2::GFP+ cells through time. Color spots
depict examples of some of the migrating ETV2::GFP+ cells. Scale bars, 50 mm, and time (t) is given in hr:min:sec.
(B) Hierarchical clustering and heatmap for depicted genes in the GFP+FLK1+CD41 cell population sorted from E7.5 and E8.5 (EP) ETV2::GFP embryos.
(legend continued on next page)
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and Movies S1, S2, S3, and S4, representative examples of
migrating ETV2::GFP+ cells are traced over time during the
course of ex vivo embryonic development. These data revealed
extra-embryonic ETV2+ cells at the boundary between extra-
and intra-embryonic regions migrating to the intra-embryonic
region as the embryo progresses toward the E8.5 stage. These
findings demonstrate that E7.5 extra-embryonic ETV2+ cells
are contributing to the pool of E8.5 intra-embryonic ETV2+ cells.
E7.5 and E8.5 ETV2+FLK1+ Cells ShowDifferential Level
of Runx1 Expression
In order to define the underlying molecular mechanisms that
contribute to the differential hemogenic potential, we performed
a comparative global gene expression profiling of the E7.5
and E8.5 (EP) ETV2::GFP+FLK1+CD41 populations. Principal-
component analysis (PCA) confirmed close association among
biological replicates but also clear differences between the
two populations (Figure S2A). In addition, the gene expression
profile of the ETV2+ progenitors was clearly separate from
the Runx1+VECadCD41+ primitive hematopoietic population,
which represents a committed hematopoietic population (Ta-
naka et al., 2012b) (Figures S2A and S2B). Greater than 2-fold
expression differences were observed in a total of 1,022 genes,
of which 627 were expressed at higher levels and 395 showed
lower levels in the E7.5, as compared to the E8.5 (EP) population
(Figure 2B). Despite these differences in gene expression, both
populations had similar expression of endothelial genes, indi-
cating their shared endothelial identity (Figure S2C). Brachyury
(T), an early mesoderm marker, and Etv2 were expressed at
lower levels in the E8.5 (EP) population (Figure 2C). In line with
the direct relationship between these two populations, this might
reflect the progressive downregulation of a hemangioblast
mesoderm identity, as the ETV2+ cells further differentiate from
their mesodermal origin and migrate from the extra-embryonic
region toward the intra-embryonic region. Similarly indicative
of a progressive transition, Hbb-bh1, a marker of primitive eryth-
ropoiesis taking place in the YS, was also expressed at lower
levels in the E8.5 (EP) population. Runx1 followed a similar
pattern of expression and was, in fact, one of the few hemato-
poietic transcription factors differentially expressed between
the two ETV2::GFP+FLK1+ populations, along with Gata1 and
Gata2 (Figure 2C). This pattern of Runx1 expression was linked
to the activity of the proximal P2 promoter that generates the
Runx1b isoform transcript, since the Runx1c isoform transcript
(regulated by the distal P1 promoter) was absent in both popula-
tions (Figure 2B). Runx1b is the Runx1 isoform that is specifically
expressed in HE at the onset of EHT (Sroczynska et al., 2009).
The transcription factors Scl and Fli1, which are part of a recur-
sive triad along withGata2 (Pimanda et al., 2007b) known to con-
trol hematopoietic development, were expressed at similar
levels in the two populations (Figure 2D). Gene set enrichment(C) RT-qPCR for some of the differentially expressed genes found in the exon arra
and Runx1b+c (Runx1all). Data are means of triplicate experiments ± SD; two-ta
(D) Exon array gene expression for hematopoietic transcription factors. Error bar
(E) GSEA analysis depicting significantly enriched molecular processes in the
GFP+FLK1+CD41 population. NES: normalized enrichment score; FDR: false di
See also Figure S2 and Movies S1, S2, S3, and S4.analysis (GSEA) revealed high enrichment for hematopoietic pro-
genitors as well as SMAD1/5, BMP4, and Runx1-Runx1t1 path-
ways within genes that were expressed at higher levels in E7.5
cells, as compared to E8.5(EP) cells (Figure 2E). These results
suggest that the BMP4-SMAD1/5 pathway and Runx1 activation
in E7.5 ETV2::GFP+FLK1+ cells could be implicated in the under-
lying mechanisms of the high hemogenic potential of this popu-
lation at E7.5. Altogether, these data suggest a pre-eminent role
for RUNX1 in the temporal control of the hemogenic ability of
ETV2+ progenitor cells during early embryonic development.
Heterogeneity within E7.5-E8.5 ETV2::GFP+ Progenitors
Given that FLK1 and ETV2 are also expressed in hemangio-
blast prior to HE emergence (Wareing et al., 2012a), the
ETV2::GFP+FLK1+CD41 sorted cells are likely to be heteroge-
neous in nature. In order to assess their degree of heterogeneity,
we performed single-cell gene expression analysis on a total of
262 ETV2::GFP+FLK1+CD41 single cells from E7.5, E8.5 (EP),
and E8.5 (YS) ETV2::GFP+ embryos using a nanofluidic platform.
A total of 96 genes were analyzed, including housekeeping
genes, cell-cycle genes, and transcription factors involved in
mesoderm, endothelial, and hematopoietic development. Unsu-
pervised hierarchical clustering and PCA analysis showed that
the E8.5 (EP) and E8.5 (YS) populations cluster closely together
and are distinct from the E7.5 cells (Figures 3A and 3B). Heatmap
and violin plots revealed a high and overall unimodal expression
of cell-cycle genesMki67, Cdk4,Mcm6, Ccnd3, and Pcna, sug-
gesting that the higher hematopoietic potential of the E7.5
ETV2+FLK1+ cells was not due to increased proliferation. As ex-
pected, Flk1 (Kdr) expression was also high in all populations,
while Bmp4 was downregulated in E8.5, a finding consistent
with the global expression data. Similarly, while Runx1b was ex-
pressed at high levels in most E7.5 single cells (72 out of 80), only
24 out of the 103 E8.5 (EP) and 20 out of the 79 E8.5 (YS) single
cells expressed this transcription factor (Figure 3C; Figure S3).
Heterogeneity in the expression of hematopoietic genes such
as Ikzf2 and Itga2b was also observed in the E8.5 (EP) popula-
tion, while E7.5 displayed an overall high expression pattern for
a number of hematopoietic transcription factors. In contrast,
the majority of the E8.5 cells analyzed had low or undetectable
expression levels of hematopoietic genes such as Myb or Spi1
(Figure 3C). Unsupervised hierarchical clustering for all genes
showed that some E7.5 single cells clustered closer to the
E8.5 (EP) cells rather than to the E7.5 population (Figure 3A).
This E7.5 subset that clustered with the E8.5 population ex-
pressed Runx1 (13 out of 17 cells), the majority of which (11
out of 13 Runx1+ cells) were Gata1 and could represent the
migrating RUNX1+GATA1 cell population previously described
(Tanaka et al., 2014). Interestingly, a small subset of cells in each
population was negative for Etv2 (Figure S3). The E7.5 Etv2
cells expressed hematopoietic genes and could represent cellsy. Three primer sets are used for detection of Runx1 isoforms: Runx1b,Runx1c,
iled Student’s t test. *p < 0.05.
s indicate SD.
gene set correlated with low gene expression in E8.5 compared to an E7.5
scovery rate.
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that progressed further toward hematopoiesis; the Etv2 E8.5
(EP) and E8.5 (YS) cells did not express hematopoietic genes.
A subset of Etv2 cells, including E8.5 (EP) and E8.5 (YS) cells,
expressed a strong endothelial signature and could represent
cells further committed to the endothelial lineage. A third subset
of Etv2 cells only detected in E8.5 (EP) had low or undetectable
expression of either endothelial or hematopoietic genes. These
cells, only found in the EP, could represent progenitors differ-
entiating toward cardiac fate, in line with a previous report
demonstrating the necessity for Etv2 silencing for cardiac differ-
entiation (Schupp et al., 2014) (Figure S3). Altogether, these sin-
gle-cell analyses not only confirmed data from the microarray
analysis on the bulk population but also revealed the hetero-
geneity within ETV2::GFP+FLK1+CD41 populations at different
developmental stages.
RUNX1 and ETV2 Are Co-expressed in E7.5 but Not in
E8.5 Embryos
The global expression profiling and single-cell data analysis re-
vealed a distinct pattern of Runx1 mRNA expression between
E7.5 and E8.5 ETV2::GFP+ cells. To further explore their expres-
sion pattern, we crossed Etv2::gfp (Wareing et al., 2012a) and
Runx1b::rfp (Sroczynska et al., 2009) transgenic mice to concur-
rently assess the expression of both genes in situ. At E7.5, both
RUNX1b::RFP and ETV2::GFP were found co-expressed in
FLK1+ cells in the blood islands in the YS (Figures 4A and 4C;
Movie S5). ETV2::GFP alsomarked cellsmigrating from the prim-
itive streak toward the extra-embryonic mesoderm (Figure 4A).
At E8.5, ETV2::GFP was no longer detected in the YS blood
islands, whereas RUNX1b::RFP was expressed in FLK1 cells,
likely representing primitive blood cells (Figure S4A). The allan-
tois was the only extra-embryonic tissue that retained high
expression of ETV2::GFP but lacked expression of RUNX1b::
RFP at E8.5 (Figure S4B). In the E8.5 (EP), ETV2::GFP had a
broad pattern of expression, as it was found expressed along
the dorsal aorta, the sprouting inter-somitic vessels, the cephalic
mesenchyme, and the endocardium. ETV2::GFP+FLK1+ cells
exhibited no or minimal expression of RUNX1b::RFP (Figures
4B and 4C; Movie S6). At E9.5, ETV2::GFP expression was
downregulated but still widely expressed, while RUNX1b::RFP
expression was observed within the P-Sp region. By E10.5, em-
bryos no longer expressed ETV2::GFP, while RUNX1b::RFP was
expressed in circulating blood cells (Figure 4C).
In the gastrulating embryo, Indian hedgehog is secreted
from visceral endoderm and stimulates the expression of
BMP4 from the extraembryonic mesoderm. BMP4, in turn, feeds
back to mesodermal cells (in an autocrine or paracrine manner)
to induce the hematopoietic and endothelial programs (Baron,
2001; Dyer et al., 2001). It was previously shown that BMP4 posi-
tively regulates the expression of Runx1b via the SMAD1/5Figure 3. Single-Cell Gene Expression Analysis Reveals Heterogeneity
(A) The Fluidigm platform was used for single-cell gene expression analysis as
archical clustering heatmap for depicted genes.
(B) PCA for the cells analyzed shows the degree of segregation among the three
(C) Frequency of distribution of the expression level for each gene shown as Vio
expression level.
See also Figure S3.pathway (Pimanda et al., 2007a). Therefore, we hypothesized
that ETV2::GFP+FLK1+ cells in the YS that expressed high levels
of RUNX1b also expressed BMP4 and activated SMAD1/5.
Indeed, at E7.5, BMP4 was detected at high levels in GFP+ cells
in the blood islands and in the allantois (Figure 5A). Accordingly,
part of the ETV2::GFP+ cells in the blood islands also showed
staining for phosphorylated SMAD1/5 (Figure 5B). In contrast,
E8.5 ETV2::GFP+ cells did not express detectable levels of either
BMP4 or pSMAD1/5 (Figures 5C and 5D). Altogether, staining in
E7.5-E8.5 embryos revealed a contrasting pattern of RUNX1
expression in ETV2+ cells. ETV2-expressing cells at E7.5 showed
high expression of BMP4 and active SMAD1/5 that could under-
lie the mechanism of RUNX1b expression. In contrast, ETV2+
cells in the E8.5 (EP) did not express BMP4 or active Smad1/5
and lacked detectable expression of RUNX1b.
Runx1b Ectopic Expression Restores the Hemogenic
Potential of E8.5 ETV2::GFP+FLK1+ Cells
Given that higher expression of Runx1 in ETV2::GFP+FLK1+
CD41 cells correlated with higher hemogenic potential at E7.5
when compared to the E8.5 stage, we hypothesized that the
expression of Runx1b might potentially restore the ability of
E8.5 endothelial progenitor cells to produce hematopoietic
cells. Therefore, we sorted E8.5 (EP) ETV2::GFP+FLK1+CD41
cells, transduced them with Runx1b or control empty lentivirus,
and tested their hemogenic potential (Figure 6A; Figures S5A
and S5B). Live imaging revealed that, while both control and
Runx1-treated cultures generated adherent endothelial cores,
only Runx1-treated cells generated floating hematopoietic cells
(Figure 6B; Movie S7). Interestingly, Runx1-treated cells gave
rise to a 10-fold higher number of hematopoietic colonies
compared to the control-treated cells (Figures 6C and 6D). Taken
together, these data reveal that Runx1 expression alone is suffi-
cient to confer hematopoietic potential to ETV2+FLK1+ endothe-
lial progenitors.
Runx1b Increases the Frequency of E8.5
ETV2::GFP+FLK1+ Cells with HE Potential
The effect of Runx1 expression on E8.5 ETV2::GFP+FLK1+
CD41 cells could be attributed either to an increase in the pro-
liferation rate of the few HE cells present in this population or an
increase in the number of cells that displayed HE potential. To
address this, we performed western blot analysis on control
and Runx1-treated E8.5 ETV2::GFP+FLK1+CD41 cultures for
proliferating cell nuclear antigen (PCNA), but no change in
PCNA protein levels was detected (Figure S5B). Cell-cycle anal-
ysis also showed no substantial change in the percentage of
cells in S phase (Figure S5C). These results suggest that
RUNX1 is not mediating its effect through a change in prolif-
eration. To determine the effect of Runx1b on the frequency ofin ETV2::GFP-Expressing FLK1 Cells
described in the Supplemental Experimental Procedures. Unsupervised hier-
populations.
lin plots. The width of the violin plot represents the frequency of cells at that
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ETV2+FLK1+ cells that acquire HE potential, we performed a
limiting dilution assay (LDA) on control and Runx1-treated cells.
Runx1-transduced ETV2::GFP+FLK1+CD41 cultures had a far
greater frequency of cells giving rise to hematopoietic cells as
compared to control (Figure 6E). In conclusion, the low fre-
quency of hematopoietic cells generated by the control-trans-
duced cells indicates that the HE potential of these cells is rare
(1 in 8422). Once E8.5 ETV2+FLK1+ cells ectopically express
Runx1, they show a dramatic increase in their capacity to give
rise to hematopoietic colonies (1 in 70), an effect that is indepen-
dent of the proliferative state of these cells. Altogether, these
data suggest that the ability of ETV2::GFP+FLK1+CD41 endo-
thelium progenitors in the developing embryo to give rise to he-
matopoietic cells is mainly dependent on Runx1 expression.
BMI1 Inhibition De-represses Runx1 Expression and
Confers Hemogenic Potential to E8.5 ETV2::GFP
Endothelial Progenitors
The single-cell gene expression analysis and ETV2::GFP embryo
staining revealed that Bmi1 was highly expressed in E8.5 intra-
embryonic ETV2::GFP cells but was absent or expressed at
low levels in the E7.5 ETV2::GFP population (Figure 7A; Figures
S6A and S6B). BMI1 is a RING finger protein and an integral
component of the Polycomb Repressive Complex 1 (PRC1)
that mediates epigenetic silencing of targeted genes (Buchwald
et al., 2006; Schwartz and Pirrotta, 2008). A previous study
showed that Runx1 was downregulated by BMI1 in K562 cells
(Shen et al., 2014). Thus, we hypothesized that PRC1 represses
Runx1 transcription in E8.5 ETV2::GFP+ cells, thereby suppress-
ing the hematopoietic transcriptional program and the HE poten-
tial of these progenitors. To test this, we first used PRT4165,
a pharmacological inhibitor of the BMI1/RING1-mediated
E3 ubiquitin ligase activity of PRC1 (Alchanati et al., 2009).
PRT4165-mediated BMI1 inhibition was confirmed by a
decrease in H2AK119 ubiquitination, a target of PRC1, in FLK1+
cells derived from day 3 embryoid body cultures (Figure 7B).
To assess BMI1 inhibition on endothelial progenitors, E8.5
ETV2::GFP+FLK1+CD41 cells were sorted and cultured on an
OP9 stroma layer with PRT4165 or DMSO and tested for the
expression of hematopoietic genes (Figure 7C). Interestingly,
Runx1 expression was upregulated upon BMI1 inhibition along
with other hematopoietic genes, including Itga2b and Spi1 (Fig-
ure 7D). Similarly, Bmi1 silencing, using small interfering RNA
(siRNA), also resulted in an increase in the expression of hemato-
poietic genes (Figure S6C). BMP4, an upstream regulator of
Runx1 showed no significant change upon BMI1 inhibition and
silencing. To determine the effect of BMI1 inhibition on their
HE potential, PRT4165- or DMSO-treated cells were further
cultured in a cocktail of cytokines to promote hematopoiesis.
Fluorescence-activated cell sorting (FACS) analysis and May-
Gr€unwald-Giemsa staining showed a strong increase in CD45+Figure 4. Expression Pattern of RUNX1b and ETV2 in Developing Emb
(A and B) Transversal section of Etv2::gfp Runx1b::rfp E7.5 (A) and E8.5 (B) embr
bars, 50 mm.
(C) Whole-mount imaging for ETV2::GFP RUNX1b::RFP and CD31 for E7.5-E1
BI: blood island; H: head; ISV: intersomitic vessel; da: dorsal aorta; ec: endocard
See also Figure S4 and Movies S5 and S6.and CD11b+ hematopoietic cells upon BMI1 inhibition (Figures
7E–7G). Altogether, these results indicate that PRC1 inhibition
de-represses Runx1 expression and, consequently, activates
the hematopoietic program in E8.5 ETV2::GFP+ endothelial pro-
genitors conferring them HE potential.
We also assessed the expression of BMI1 in the YS and AGM
at E8.5 and E10.5, respectively (Figure S7). BMI1 was expressed
in CD31+ cells and at moderate levels in CD41+ cells (Figures
S7A and S7B). Given that there are no markers to distinguish
HE from endothelial progenitors, it is not clear whether BMI1
expression is restricted to endothelial progenitors. Similarly to
BMI1, BMP4 was also detected in both CD31+ and CD41+
E8.5, but its expression was reduced in ETV2:GFP+ progenitors
(Figures S7C and S7D). In the E10.5 AGM, BMI1 was detected in
both the CD31+cKIT endothelial layer and in CD31cKIT+
emerging hematopoietic clusters (Figure S7E). This suggests
that, by E10.5, other mechanisms beyond the BMI1-polycomb
complex are involved in repressing the hematopoietic program
in endothelial cells, as previously shown (Lizama et al., 2015).
Overall, these data suggest that the BMI1-mediated mechanism
of Runx1 suppression is restricted to the E8.5 intra-embryonic
ETV2::GFP+ progenitor population.
DISCUSSION
A large body of work has emerged recently regarding the role of
ETV2 at the onset of blood and endothelium specification (Oh
et al., 2015). The expression of ETV2 is restricted to a narrow
window of embryonic development between E7.0 and E9.5
(Koyano-Nakagawa et al., 2012; Wareing et al., 2012a). In the
absence of ETV2, mesodermal progenitors differentiate to the
cardiomyocyte fate concomitantly with a complete defect in he-
matopoiesis and vasculogenesis (Liu et al., 2013; Palencia-Desai
et al., 2011). It is now clear that the expression of ETV2 in FLK1+
is essential for the progression to hematopoiesis and endothe-
lium (Wareing et al., 2012a). However, the molecular mecha-
nisms that confer hemogenic competence to ETV2-expressing
FLK1+ progenitors are poorly understood.
Here, we investigated the hemogenic potential of ETV2+FLK1+
progenitor populations at the early stages of embryogenesis, us-
ing a well-characterized ETV2::GFP reporter mouse (Wareing
et al., 2012a). We found that both the E7.5 extra-embryonic
and E8.5 intra-embryonic ETV2::GFP+ cells share similar expres-
sion of HE markers while lacking expression of CD41. However,
when cultured under conditions that promote HE maintenance
and growth, the E8.5 population appeared to maintain an endo-
thelial identity, while the E7.5 population downregulated the
expression of endothelial markers in CD41+ emerging cells.
Accordingly, E8.5 cells gave rise to very few hematopoietic col-
onies in clonogenic assays, compared to the E7.5 population.
Global gene expression analysis identified Runx1 as one of theryos
yos stained for ETV2::GFP (green), Runx1b::RFP (red), and FLK1 (white). Scale
0.5 developmental stages. Pr: Proximal; D: Distal; A: Anterior; P: Posterior;
ium; and P-Sp: para-aortic splanchnopleura region.
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Figure 5. BMP4-pSMAD1/5 Activity in E7.5 Underlies the High Hematopoietic Potential of the ETV2::GFP Cells
(A) E7.5 ETV2::GFP embryos were stained for GFP (green) and BMP4 (red). BI: blood island; Al: allantois.
(B) Serial section of the same E7.5 embryo used in (A) was used for staining with GFP and pSMAD1/5. (C) E8.5 ETV2::GFP embryos were stained for GFP (green)
and BMP4 (red).
(D) E8.5 ETV2::GFP embryo stained for pSMAD1/5 (red).
Scale bars, 50 mm for whole-embryo images and 15 mm for magnified images.
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Figure 6. RUNX1b Ectopic Expression in
E8.5 ETV2::GFP+FLK1+ Cells Enhances Their
Hematopoietic Potential
(A) Schematic representation of the experimental
design.
(B) Time-lapse imaging during the three-day OP9
culture of cells transduced with control or Runx1
lentivirus. White arrows indicate endothelial clus-
ters; red arrows indicate hematopoietic cells.
(C) Clonogenic assay for hematopoietic pro-
genitors of control and Runx1b transduced cells
after three days of culture on OP9 stroma layer.
Left graph shows the number of hematopoietic
colonies formed for each type of hematopoietic
CFU. Right graph shows the overall change in CFU
number per treatment. Error bars represent 1 SD
from three independent experiments. *p < 0.05.
Mix, GEMM/GEM; GM: granulocyte-macrophage;
Mac: macrophages; EryP: primitive erythrocytes;
and EryD: definitive erythrocytes.
(D) Examples of hematopoietic colonies at day
eight of replating in semisolid clonogenic assay.
Scale bars represent 500 mm.
(E) Left: limiting dilution assay (LDA) of hemo-
genic potential of FLK1+GFP+CD41-sorted cells
derived from E8.5 ETV2::GFP embryos and in-
fected with either control or Runx1 lentivirus before
plating on OP9 stoma. Right: example of hemato-
poietic cells emerging in OP9 cultures indicative
of hemogenic endothelial potential in LDA. Data
shown are representative of two independent
experiments.
See also Figure S5 and Movie S7.few hematopoietic transcription factors highly differentially ex-
pressed between the two ETV2::GFP+FLK1+CD41 popula-
tions, a finding confirmed by in situ immunofluorescence and
single-cell expression analysis. To examine the functional role
of Runx1 in ETV2::GFP+FLK1+CD41 cells, we ectopically ex-
pressed Runx1 in the population isolated from E8.5 embryos.
Interestingly, Runx1 expression dramatically increased the he-
mogenic potential of these cells, demonstrating that the expres-
sion of Runx1 on its own is sufficient to confer hemogenic
competence to ETV2+ progenitors. To investigate the relation-
ship between the E7.5 and E8.5 ETV2+ populations, we per-
formed time-lapse microscopy. Live-imaging analysis showed
the migration of ETV2+ cells from the extra-embryonic site
to the intra-embryonic site, suggesting that at least a subset of
the E8.5 ETV2+ cells arise from E7.5 extra-embryonic progeni-
tors. Our data, however, did not determine whether the ETV2-
migrating cells previously expressed or not RUNX1. Whether
Runx1 is transiently expressed at an earlier stage of develop-
ment contributing later to endothelium and hematopoiesis has
been previously investigated. Tanaka et al. published a study
showing the migration of RUNX1+GATA1 cells from extra- to
intra-embryonic endothelium (Tanaka et al., 2014). FurtherCellwork also suggested the early and tran-
sient expression of RUNX1 in progeni-
tors contributing to late hematopoiesis
(Samokhvalov et al., 2007; Tanaka et al.,
2012a). However, the conclusions ofthese studies remain disputed; therefore, further work will be
required to fully address this issue.
Our study suggests that Runx1 expression is repressed in
endothelial progenitors at the early stages of embryonic devel-
opment via a BMI1-dependent mechanism to limit hematopoi-
etic potential to a subset of progenitors. Our results demonstrate
that ectopic expression of Runx1 alone is sufficient to confer he-
mogenic competence to E8.5 FLK1+ETV2+ endothelial progeni-
tors. These findings reveal that the entire molecular framework
required for blood specification is present in these endothelial
progenitors, with the notable exception of RUNX1. A chromatin
immunoprecipitation (ChIP)-sequencing study has shown the
importance of RUNX1 in orchestrating the formation of hemato-
poietic-specific transcription binding pattern at the onset of he-
matopoiesis (Lichtinger et al., 2012). This study showed that
Runx1 induction in Runx1/ HE results in a rapid shift in the
binding of SCL and FLI1 on hematopoietic genes, an increase
in histone acetylation, and the formation of new transcription
factor complexes. It is possible that, in E8.5 endothelial progen-
itors, these RUNX1-mediated changes do not occur due to a lack
of Runx1 expression, hence resulting in the maintenance of the
endothelial program.Reports 15, 2185–2199, June 7, 2016 2195
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Figure 7. Inhibition of BMI1 De-represses Runx1 Expression and Confers Hemogenic Potential to E8.5 ETV2::GFP Endothelial Progenitors
(A) Single-cell gene expression analysis for Bmi1 in E7.5 and E8.5 (EP) ETV2::GFP+FLK1+CD41 progenitors. Error bars represent 1 SEM for at least 54 single
cells. **p% 0.001.
(B) Western blot analysis for ubiquitinylated H2AK119, a downstream target of the PRC1 complex. FLK1+ sorted cells from day-3 embryoid body cultures were
treated with 25 mM PRT4165 inhibitor or DMSO for 3 days prior to protein isolation.
(C) Schematic representation of the experimental design.
(legend continued on next page)
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An earlier study focused on the mechanisms by which
hematopoiesis is restricted to the HE domain during embryonic
development; HOXA3 expression in the intra-embryonic vascu-
lature was shown to restrain hematopoietic differentiation of
endothelial progenitors by downregulating Runx1 expression
(Iacovino et al., 2011). Our work proposes an additional mecha-
nism of hemogenic competence restriction. We show that
BMI1, a subunit of the PRC1 complex, is highly expressed in
E8.5 ETV2::GFP+FLK1+CD41 but not detectable in E7.5
ETV2::GFP+FLK1+CD41 cells. BMI1 inhibition in the E8.5 pop-
ulation resulted in not only an increase inRunx1 expression along
with other hematopoietic genes but also an increased HE poten-
tial. The role of BMI1 in suppressing HE potential was shown
here, using an ex vivo experimental approach. Future in vivo
studies will need to be performed to fully confirm the role of
BMI1 in this mechanism. While the role of BMI1 at later stages
of hematopoiesis is well-established (Ding et al., 2012), its role
in early endothelial progenitors was not previously addressed.
Our data indicate that the BMI1 mechanism of Runx1 repression
is present only in a narrow window of development when ETV2+
progenitors are present at the E8.5 stage. The role of BMI1 in
ETV2+ endothelial progenitors is clearly distinct from its role in
committed hematopoietic cells. E8.5 ETV2+ cells are endothelial
progenitors, E8.5 CD41+ YS cells aremostly committed primitive
erythroid cells, including primitive and definitive progenitors (Fer-
kowicz et al., 2003), and E10.5 cluster cells are mostly HSCs and
pre-HSCs (Boisset et al., 2015; Rybtsov et al., 2011; Taoudi
et al., 2008). The recruitment of BMI1 to specific DNA regions
for silencing is cell context dependent and is unlikely to be iden-
tical in endothelium, primitive erythroid cells and embryonic pre-
HSCs/HSCs. In support of this cell-context dependency within
cell populations of the hematopoietic system, an additional
role for BMI1 was recently described in erythroid cells where
BMI1 is implicated in the regulation of ribosome biogenesis
(Gao et al., 2015), clearly different from its role in adult HSCs,
where BMI1 is implicated in the silencing the p16Ink4a p19Arf
locus (Park et al., 2003).
Our data identify an additional role for BMI1 in maintaining an
endothelial fate in E8.5 Etv2-expressing progenitors. This finding
suggests that, in E8.5 ETV2+ progenitors, the hematopoietic pro-
gram is silenced via a PRC1-mediated repression mechanism.
The ectopic re-expression of Runx1 or its de-repression via
BMI1 inhibition or silencing results in the acquisition of hemo-
genic fate, suggesting that the hematopoietic program needs
to be repressed for further progression of the endothelial fate
during embryonic development. It remains to be determined
whether BMI1 has a direct or indirect effect onRunx1. A previous
study has shown that SUZ12, a component of the PRC2, directly
binds Runx1 as well as Bmp4 gene loci (Lee et al., 2006). Given
the synergistic action of PRC1 and PRC2, it is likely that the(D) RT-qPCR for E8.5 ETV2::GFP+FLK1+CD41 cells cultured in HE conditions and
bars represent 1 SEM for at least five experiments (expect for BMP4, n = 4). *p <
(E) FACS analysis of day-8 hematopoietic culture for the expression of hematop
(F) Emergence of hematopoietic colonies after 8 days in hematopoietic culture c
(G) Representative May-Giemsa staining from PRT4165-treated cells after 8 day
Mk: megakaryocyte; P: progenitor, and scale bars, 20 mm.
See also Figure S6.BMI1-containing PRC1 complex mediates the repression of
Runx1. Our results show that Bmp4 downregulation is indepen-
dent of BMI1-mediated action, but it remains to be determined
whether PCR2 alone is implicated in this process. This molecular
mechanismof differential specification to blood and endothelium
is consistent with the proposed evolutionary development of the
circulatory and blood system. While blood cells are found in all
multicellular organisms of the animal kingdom, the presence of
endothelial cells is restricted to the vascular system of the verte-
brate phyla (Mun˜oz-Cha´puli et al., 2005). A prevalent hypothesis
for the evolutionary origin of endothelium proposes that the
early endothelium of vertebrates might have arisen from circula-
tory amoebocytes or hemal blood cells through the repression
of the blood program and the acquisition of epithelial-type
morphology (Mun˜oz-Cha´puli et al., 2005; Pascual-Anaya et al.,
2013). Our findings lend support to this hypothesis and suggest
that this evolutionary mechanismmight still be preserved in early
ETV2+ endothelial progenitors.
Our study suggests that, during embryonic development,
blood and endothelium cell fates are differentially established
through the active repression of RUNX1 in common progenitors
to allow endothelial fate to proceed. This mechanism of alterna-
tive repression of cell fates during early mesoderm specification
is reminiscent of the repression of the cardiomyocyte fate by
SCL in prospective HE (Van Handel et al., 2012). Altogether,
our results raise questions about the plasticity of early meso-
derm progenitors and the window of opportunity for differential
cell fates that might help us devise more efficient protocols for
the derivation of repopulating blood progenitors in vitro.
EXPERIMENTAL PROCEDURES
Mice
Timed matings were set up between Etv2::gfp (Wareing et al., 2012a) males
and ICR females or between Etv2::gfp and Runx1b::rfp mice as described in
Sroczynska et al. (2009) study, except that the hCD4 reporter was replaced
with red fluorescent protein [RFP] heterozygote mice. The morning of the
vaginal plug was considered as E0.5. All animal work was performed accord-
ing to the United Kingdom Animal Scientific Procedures Act 1896.
Embryo Cell Culture
Sorted populations were seeded on irradiated OP9 stroma cells in Iscove’s
modified Dulbecco’s medium (IMDM) containing 10% fetal bovine serum
(FBS), 4 mM L-glutamine, 50 U/ml penicillin/streptomycin (Pen/Strep), 0.6%
transferrin, 2% leukemia inhibitory factor (LIF), 48.75 mg/ml monothiolglycerol,
25mg/ml ascorbic acid, 2%LIF, 1%kit ligand (KL) supernatant, 10 ng/ml oncos-
tatin M, 1 ng/ml basic fibroblast growth factor (bFGF), and 1 mg/ml osteopontin.
Where indicated, cells were cultured in semisolid clonogenic assay (Wareing
et al., 2012a). BMI1/RING1A inhibitor PRT4165 (Tocris) was used at 25 mM.
Lentiviral Transduction
PCR-amplified Runx1b and Tomato cDNAs separated by a 2A sequence (de
Felipe et al., 1999) were cloned into a lentiviral vector containing the humantreated with DMSO or 25 mMPRT4165 for 3 days prior to RNA extraction. Error
0.05.
oietic markers.
onditions. Scale bars, 500 mm.
s in hematopoietic culture conditions. Gr: granulocytes; Mac: macrophages;
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EF1 promoter (Gilham et al., 2010). VSVg-pseudotyped lentiviral particles were
produced and titered as previously described (Dull et al., 1998).
Flow Cytometry
Single-cell suspensions were stained with FLK1-Biotin, CD41-APC, TIE2-PE,
or cKIT-APCeF780 followed by Streptavidin-PECy7 (eBioscience). Cells were
sorted using Aria II, Aria III, or Influx and analyzed with an LSRII cytometer
(BD Biosciences).
Statistical Analyses
Data were analyzed using a Student’s t test. Significant differences are *p <
0.05 and **p% 0.001.
Additional information is available in the Supplemental Experimental
Procedures.
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